转移淋巴结数量对非小细胞肺癌第八版TNM分期的预后影响
研究分析2003至2012年接受完全性肺叶或全肺切除并肺门及纵隔淋巴结清扫的1989例非小细胞肺癌患者,按转移淋巴结数量和站数分层,评估总生存。多因素分析显示,病理N1(参照病理N2)和单枚淋巴结转移(参照多枚)为独立预后因素,单站转移(参照多站)则不是。在病理N1和N2各自的多因素分析中,转移淋巴结数≥3、≥4、≥5枚(分别参照1–2、1–3、1–4枚)均为独立预后因素。
要点
- 全部患者多因素分析中,病理N1(参照病理N2)与单枚淋巴结转移(参照多枚)为独立预后因素。
- 病理N1患者中多枚淋巴结转移(参照单枚)为独立预后因素,风险比1.41,p=0.04。
- 病理N2患者中多枚淋巴结转移(参照单枚)不是独立预后因素。
核心结论
- 转移淋巴结数量在现有病理N分期之外对生存有强烈影响。
- 为明确其预后影响,需在其他数据集(包括接受非手术治疗的患者)中进一步研究。
研究设计与样本
- 回顾性分析1989例2003至2012年接受完全性切除(肺叶或全肺切除并肺门及纵隔淋巴结清扫)的非小细胞肺癌患者。
- 按转移淋巴结数量、站数及当前病理N分类对患者分组,分析各组总生存及组合的生存影响。
主要发现
- 全部患者多因素分析中,病理N1(参照病理N2)和单枚淋巴结转移(参照多枚)为独立预后因素,单站转移(参照多站)不是。
- 病理N1患者多因素分析中,多枚淋巴结转移(参照单枚)为独立预后因素,风险比1.41,p=0.04。
- 病理N2患者多因素分析中,多枚淋巴结转移(参照单枚)不是独立预后因素。
- 转移淋巴结数≥3枚(参照1–2枚)、≥4枚(参照1–3枚)、≥5枚(参照1–4枚)在病理N1和N2中均为独立预后因素。
关键数值与推荐
- 病理N1患者多枚淋巴结转移(参照单枚)的风险比为1.41,p=0.04。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出需在其他数据集(包括接受非手术治疗的患者)中进一步研究以明确预后影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Current nodal staging of NSCLC is defined only by anatomical location of lymph nodes (LNs). The aim of this study is to investigate prognostic impacts of the number of metastatic LNs by stratifying the present N classification. METHODS: We analyzed 1989 patients with NSCLC who underwent complete resection by lobectomy or pneumonectomy involving dissection of the hilar and mediastinal LNs from 2003 to 2012. We classified patients according to the number of metastatic nodes and stations and their current category of metastatic LNs. We analyzed the overall survival in each group and assessed the survival impact of the combination of them. RESULTS: In the multivariate analyses of all patients, pathological N1 (pN1) (reference [ref.] pN2) and single-node metastasis (ref. multiple-node) were independent prognostic factors whereas single-station metastasis (ref. multiple-station) was not. In the respective multivariate analyses of pN1 and pN2 disease, multiple-node metastasis (ref. single-node) was an independent prognostic factor in pN1 disease (hazard ratio: 1.41, p = 0.04), but not in pN2 disease. Investigation for other boundaries of a number of metastatic LNs of three or more (ref. one to two), four or more (ref. one to three), and five or more (ref. one to four) found that all of them were independent prognostic factors in both pN1 and pN2 diseases. CONCLUSIONS: The number of metastatic LNs had a strong impact on survival in addition to the current pN classification. To clarify its prognostic impact, further study is needed in other datasets including patients treated by nonsurgical modalities.
引用
- Katsumata S, Aokage K, Ishii G, et al. Prognostic Impact of the Number of Metastatic Lymph Nodes on the Eighth Edition of the TNM Classification of NSCLC. J Thorac Oncol. 2019. PMID: 31055075. doi:10.1016/j.jtho.2019.04.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。